Healthcare -
Biotechnology - NASDAQ - US
$ 1.565
7.19 %
$ 101 M
Market Cap
-1.01
P/E
INZY - STOCK-BASED COMPENSATION
Stock-based Compensation INZY - Inozyme Pharma, Inc.
7.04 M
LAST VALUE
-0.89%
2 YEAR CAGR
73.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR